Annual educational expenses of European urology residents and the role of sponsorship in urology training: a survey-based analysis.
residency costs
salary
sponsorship
training
training costs
urology residents
Journal
Central European journal of urology
ISSN: 2080-4806
Titre abrégé: Cent European J Urol
Pays: Poland
ID NLM: 101587101
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
08
2022
revised:
02
10
2022
accepted:
13
11
2022
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
17
2
2023
Statut:
ppublish
Résumé
The aim of this article was to evaluate the personal monetary costs associated with the urology residency. The European Society of Residents in Urology (ESRU) designed a 35-item survey and distributed it via email and social media to urology residents in Europe.Monthly net salary and educational expenses (general expenses, literature, congresses and courses) and opinions regarding sponsorship and expenditure were evaluated. Comparisons between different countries and salary cut-offs were made. A total of 211 European urology residents completed the survey from 21 European countries. The median interquartile range (IQR) age was 30 (18-42) years and 83.0% were male. A total of 69.6% receive less than €1500 net per month and 34.6% spent ≥€3000 on education in the previous 12 months. Sponsorships came mainly from the pharmaceutical industry (57.8%), but 56.4% of trainees thought that the ideal sponsor should be the hospital/urology department. Only 14.7% of respondents stated that their salary is sufficient to cover training expenses, and 69.2% agreed that training costs have an influence on family dynamics. Personal expenses during training are high, are not sufficiently covered by the salary and impact family dynamics for a majority of residents in Europe. The majority thought that hospitals/national urology associations should contribute to the educational costs. For homogeneous opportunities across Europe, institutions should strive to increase sponsorship.
Identifiants
pubmed: 36794035
doi: 10.5173/ceju.2022.173
pii: 173
pmc: PMC9903171
doi:
Types de publication
Journal Article
Langues
eng
Pagination
418-428Informations de copyright
Copyright by Polish Urological Association.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Minerva Urol Nefrol. 2020 Jun;72(3):384-387
pubmed: 32182232
Actas Urol Esp (Engl Ed). 2020 Jan - Feb;44(1):19-26
pubmed: 31542187
Virtual Mentor. 2007 Feb 01;9(2):109-12
pubmed: 23217757
JAMA Intern Med. 2016 Oct 1;176(10):1561-1563
pubmed: 27533329
Health Care Manag Sci. 2010 Sep;13(3):234-55
pubmed: 20715307
West J Emerg Med. 2019 May;20(3):485-494
pubmed: 31123550
Hum Resour Health. 2013 Mar 08;11:12
pubmed: 23496935
BMJ. 2019 Dec 3;367:l6576
pubmed: 31796508
Acad Med. 2005 Sep;80(9):809-14
pubmed: 16123458
Curr Urol Rep. 2019 Sep 2;20(10):62
pubmed: 31478112
World J Urol. 2020 Jan;38(1):239-246
pubmed: 30982099
BJU Int. 2019 Aug;124(2):349-356
pubmed: 30993851
Cent European J Urol. 2020;73(2):231-233
pubmed: 32782845
BMJ Open. 2017 Aug 23;7(8):e016822
pubmed: 28838899
Eur Urol Focus. 2018 Sep;4(5):768-773
pubmed: 28753825
Urology. 2020 Dec;146:43-48
pubmed: 32976919
J Surg Educ. 2020 Mar - Apr;77(2):309-315
pubmed: 31889692
Health Soc Work. 1991 Aug;16(3):193-202
pubmed: 1894206
Pharmacoepidemiol Drug Saf. 2003 Dec;12(8):663-7
pubmed: 14762982
J Surg Educ. 2018 Nov;75(6):e150-e155
pubmed: 30100323
Am J Surg. 2021 Jan;221(1):65-71
pubmed: 32680622